Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2005 Mar;2(1):26-35.
doi: 10.1111/j.1742-4801.2005.00082.x.

Evaluation of Tielle hydropolymer dressings in the management of chronic exuding wounds in primary care

Curt Diehm  1 , Holger Lawall
Affiliations
Clinical Trial

Evaluation of Tielle hydropolymer dressings in the management of chronic exuding wounds in primary care

Curt Diehm et al. Int Wound J. 2005 Mar.

Abstract

The concept of moist wound healing is not fully implemented in daily practice in Germany. Thus, the objective of this investigation was to evaluate the use of Tielle hydropolymer dressings in chronic exuding wounds in primary care. A total of 6,993 patients with pressure sores (26.6%), venous leg ulcers (59.8%), diabetic foot disease (9.5%) and other wounds (5.1%) were enrolled into three multicentre, open-label, single-arm, prospective phase-IV studies for an observational period of either 4 or 12 weeks. Within the 4 (12)-week study using Tielle, 43.3% (59.1%) of the wounds healed and 51.6% (36.9%) improved. Wound area was reduced by 78.2% (85.1%). Medium or strong levels of exudates were reduced from 57.4% to 6.7% (4.0%). Cosmetic results were excellent or good in 96.3%. Compared with patients' previous treatment, efficacy and tolerability were assessed as better or much better in 92.5% and 70.4%, respectively. 97.1% of the patients remained free of adverse events. The frequency of dressing changes was reduced from 5 to 3 per week (-43%). Tielle provides an effective and safe dressing in the management of chronic exuding wounds in primary care improving patient's comfort. Due to longer wearing times, Tielle may also be cost saving.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Assessment of overall wound status after completion of Tielle treatment (b) Assessment of overall wound status after completion of Tielle treatment in different wound types. Values do not add up to 100% because of missing data and/or rounding.
Figure 2
Figure 2
Assessment of cosmetic results of healed wounds after completion of Tielle treatment. Values do not add up to 100% because of misssing data and/or rounding.
Figure 3
Figure 3
Assessment of efficacy of Tielle in comparison to previous treatment. Values do not add up to 100% because of missing data and/or rounding.
Figure 4
Figure 4
Compliance with Tielle treatment in comparison to previous treatment. Values do not add up to 100% because of missing data and/or rounding.
See this image and copyright information in PMC

References

    1. Atiyeh BS, Ioannovich J, Al‐Amm CA, El‐Musa KA. Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. Curr Pharm Biotechnol 2002; 3: 179–95. - PubMed
    1. Brem H, Jacobs T, Vileikyte L et al. Wound‐healing protocols for diabetic foot and pressure ulcers. Surg Technol Int 2003;11: 85–92. - PubMed
    1. Seaman S. Dressing selection in chronic wound management. J Am Podiatr Med Assoc 2002;92: 24–33. - PubMed
    1. Fletcher J. Managing wound exudate. Nurs Times 2003;99: 51–2. - PubMed
    1. Vowden K, Vowden P. Understanding exudate management and the role of exudate in the healing process. Br J Community Nurs 2003;8(11 Suppl):4–13. - PubMed

Publication types